COVID-19 Outbreak-Global Next Generation Sequencing (Ngs) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- 119 Pages
- Region: Global
The human genome is comprised of billions of points of tiny genetic code. DNA sequencing enables researchers to decode these DNA fragments, helping uncover valuable genetic information that relates to our well-being. Until recently, though, the technology didn’t exist to accurately and quickly process, decode and analyze the human genome. In the last decade, DNA sequencing has been completely revolutionized.
Today, Next-Generation Sequencing (NGS) technology has made it possible to process and decode the entire human genome in as little as 24 hours. NGS technology applications enable unprecedented scalability and touch on all areas of DNA research, including whole genome sequencing and exome sequencing. These contemporary sequencing methods are much more sensitive, enabling clinicians and researchers alike to discover a greater volume of submicroscopic genetic mutations in our DNA.
The Next Generation Sequencing (Ngs) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Next Generation Sequencing (Ngs) industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Next Generation Sequencing (Ngs) market can be split based on product types, major applications, and important countries as follows:
Key players in the global Next Generation Sequencing (Ngs) market covered in Chapter 12:
Response Genetics, Inc.
Mayo Medical Laboratories and Mayo Clinic
InDecations Exchange Pte Ltd (INEX)
RainDance Technologies, Inc.
DNA Electronics Ltd.
In Chapter 4 and 14.1, on the basis of types, the Next Generation Sequencing (Ngs) market from 2015 to 2025 is primarily split into:
In Chapter 5 and 14.2, on the basis of applications, the Next Generation Sequencing (Ngs) market from 2015 to 2025 covers:
Hereditary Disease Detection
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
Europe (Covered in Chapter 8 and 14)
Asia-Pacific (Covered in Chapter 9 and 14)
Middle East and Africa (Covered in Chapter 10 and 14)
South America (Covered in Chapter 11 and 14)
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025